SIEMENS HEALTH ADR/050 (F:SHL1) — Market Cap & Net Worth
Market Cap & Net Worth: SIEMENS HEALTH ADR/050 (SHL1)
SIEMENS HEALTH ADR/050 (F:SHL1) has a market capitalization of $46.68 Billion (€39.93 Billion) as of September 17, 2026. Listed on the F stock exchange, this Germany-based company holds position #580 globally and #117 in its home market, demonstrating a -9.64% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying SIEMENS HEALTH ADR/050's stock price €17.80 by its total outstanding shares 2243111308 (2.24 Billion). Also see SIEMENS HEALTH ADR/050 assets under control for a full breakdown of the balance sheet.
SIEMENS HEALTH ADR/050 Market Cap History: 2018 to 2026
SIEMENS HEALTH ADR/050's market capitalization history from 2018 to 2026. Data shows growth from $41.12 Billion to $49.83 Billion (0.71% CAGR). Also see SHL1 cash flow conversion for how efficiently the company converts equity into cash flow.
SIEMENS HEALTH ADR/050 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how SIEMENS HEALTH ADR/050's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check current stock price of SIEMENS HEALTH ADR/050 for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
2.96x
SIEMENS HEALTH ADR/050's market cap is 2.96 times its annual revenue
Latest Price to Earnings (P/E) Ratio
34.03x
SIEMENS HEALTH ADR/050's market cap is 34.03 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $59.93 Billion | $21.71 Billion | $2.04 Billion | 2.76x | 29.41x |
| 2023 | $67.33 Billion | $21.68 Billion | $1.51 Billion | 3.11x | 44.62x |
| 2024 | $66.09 Billion | $22.36 Billion | $1.94 Billion | 2.96x | 34.03x |
Competitor Companies of SHL1 by Market Capitalization
Companies near SIEMENS HEALTH ADR/050 in the global market cap rankings as of September 17, 2026. Review SHL1 tangible net assets ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to SIEMENS HEALTH ADR/050 by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #125 globally with a market cap of $177.42 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #229 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #232 globally with a market cap of $107.98 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #239 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #125 | Abbott Laboratories | NYSE:ABT | $177.42 Billion | $102.03 |
| #229 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $93.75 |
| #232 | Stryker Corporation | NYSE:SYK | $107.98 Billion | $281.50 |
| #239 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
SIEMENS HEALTH ADR/050 Historical Marketcap From 2018 to 2026
Between 2018 and today, SIEMENS HEALTH ADR/050's market cap moved from $41.12 Billion to $ 49.83 Billion, with a yearly change of 0.71%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €49.83 Billion | -12.84% |
| 2025 | €57.17 Billion | -13.49% |
| 2024 | €66.09 Billion | -1.85% |
| 2023 | €67.33 Billion | +12.34% |
| 2022 | €59.93 Billion | -24.75% |
| 2021 | €79.65 Billion | +61.00% |
| 2020 | €49.47 Billion | -1.71% |
| 2019 | €50.34 Billion | +22.40% |
| 2018 | €41.12 Billion | -- |
End of Day Market Cap According to Different Sources
On Apr 24th, 2026 the market cap of SIEMENS HEALTH ADR/050 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $46.68 Billion USD |
| MoneyControl | $46.68 Billion USD |
| MarketWatch | $46.68 Billion USD |
| marketcap.company | $46.68 Billion USD |
| Reuters | $46.68 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About SIEMENS HEALTH ADR/050
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound sys… Read more